Evidence map›Paper›PMID 25983540›Full record

ArticleCancer informatics2015

Computing molecular signatures as optima of a bi-objective function: method and application to prediction in oncogenomics.

Vincent Gardeux, Rachid Chelouah, Maria F Barbosa Wanderley, Patrick Siarry, Antônio P Braga, Fabien Reyal, Roman Rouzier, Lajos Pusztai, René Natowicz

Abstract read
In one paragraph

Article in Cancer informatics, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Vincent GardeuxEISTI engineering school, Department of Computer Science, Cergy, France. ; LISSI laboratory, University of Paris-Est, Créteil, France.
Rachid ChelouahEISTI engineering school, Department of Computer Science, Cergy, France.
Maria F Barbosa WanderleyFederal University of Minas Gerais, Laboratório de Inteligência Computacional, Belo Horizonte, Brazil.
Patrick SiarryLISSI laboratory, University of Paris-Est, Créteil, France.
Antônio P BragaFederal University of Minas Gerais, Laboratório de Inteligência Computacional, Belo Horizonte, Brazil.
Fabien ReyalCurie Institute, Department of Translational Research, Paris, France.
Roman RouzierCurie Institute, Department of Surgery, Paris, France.
Lajos PusztaiBreast Medical Oncology, Yale School of Medicine, New Haven, CT, USA.
René NatowiczESIEE-Paris, University of Paris-Est, Noisy-le-Grand, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundFilter feature selection methods compute molecular signatures by selecting subsets of genes in the ranking of a valuation function. The motivations of the valuation functions choice are almost always clearly stated, but those for selecting the genes according to their ranking are hardly ever explicit.

methodWe addressed the computation of molecular signatures by searching the optima of a bi-objective function whose solution space was the set of all possible molecular signatures, ie, the set of subsets of genes. The two objectives were the size of the signature-to be minimized-and the interclass distance induced by the signature-to be maximized-.

resultsWe showed that: 1) the convex combination of the two objectives had exactly n optimal non empty signatures where n was the number of genes, 2) the n optimal signatures were nested, and 3) the optimal signature of size k was the subset of k top ranked genes that contributed the most to the interclass distance. We applied our feature selection method on five public datasets in oncology, and assessed the prediction performances of the optimal signatures as input to the diagonal linear discriminant analysis (DLDA) classifier. They were at the same level or better than the best-reported ones. The predictions were robust, and the signatures were almost always significantly smaller. We studied in more details the performances of our predictive modeling on two breast cancer datasets to predict the response to a preoperative chemotherapy: the performances were higher than the previously reported ones, the signatures were three times smaller (11 versus 30 gene signatures), and the genes member of the signature were known to be involved in the response to chemotherapy.

conclusionsDefining molecular signatures as the optima of a bi-objective function that combined the signature size and the interclass distance was well founded and efficient for prediction in oncogenomics. The complexity of the computation was very low because the optimal signatures were the sets of genes in the ranking of their valuation. Software can be freely downloaded from http://gardeux-vincent.eu/DeltaRanking.php.

Indexed as

bi-objective optimizationbreast cancerfeature selectionfilter methodmolecular signatures

Identifiers

PMID25983540
PMCPMC4426938

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.